During the past decade, Hospital São Paulo conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 3 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital São Paulo" #1 sponsor was "Federal University of São Paulo" with 12 trials, followed by "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 3 trials sponsored, "United Therapeutics" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Hospital Moinhos de Vento" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital São Paulo" #1 collaborator was "Ministry of Health, Brazil" with 3 trials as a collaborator, "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 2 trials as a collaborator, "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 2 trials as a collaborator, "Hospital Alemão Oswaldo Cruz" with 2 trials as a collaborator and "Hospital Israelita Albert Einstein" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Hospital São Paulo" are "Pulmonary Arterial Hypertension" (6 trials), "PAH" (4 trials), "Vascular Diseases" (4 trials), "Cardiovascular Diseases" (3 trials) and "Familial Primary Pulmonary Hypertension" (3 trials). Many other conditions were trialed in "Hospital São Paulo" in a lesser frequency.

Most popular intervention types in "Hospital São Paulo" are "Drug" (22 trials), "Other" (8 trials), "Procedure" (5 trials), "Device" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ralinepag" (3 trials), "Sotatercept" (3 trials), "0.9% saline" (1 trials) and "7 day antibiotic course for VAT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital São Paulo" are 34 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital São Paulo". undefined are not yet recruiting, 10 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Hospital São Paulo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital São Paulo, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 10 trials that are defined as “Not Applicable".